2011
Implantation Rate Remains Unaffected in Women with Endometriosis Compared to Tubal Factor Infertility
Matalliotakis I, Sakkas D, Illuzzi J, Matalliotaki C, Arici A. Implantation Rate Remains Unaffected in Women with Endometriosis Compared to Tubal Factor Infertility. Journal Of Endometriosis And Pelvic Pain Disorders 2011, 3: 86-92. DOI: 10.5301/je.2011.8528.Peer-Reviewed Original ResearchTubal factor infertilityMale infertilityTubal infertilityInfertility groupEndometriosis groupFactor infertilityImplantation rateAge-matched control groupMale infertility groupTubal infertility groupICSI treatment cyclesReduced pregnancy rateMethods Five hundredDelivery rateNumber of embryosConsecutive IVFIVF treatmentIVF programPregnancy rateUterine receptivityEndometriosisTreatment cyclesControl groupInfertilityPatients
2010
Assessment of Oocyte and Embryo Quality in Women with Endometriosis
Matalliotakis I, Cakmak H, Sakkas D, Matalliotaki C, Arici A. Assessment of Oocyte and Embryo Quality in Women with Endometriosis. Journal Of Endometriosis And Pelvic Pain Disorders 2010, 2: 87-94. DOI: 10.1177/228402651000200206.Peer-Reviewed Original ResearchTubal factor infertilityOocyte corona cumulus complexIntracytoplasmic sperm injectionFactor infertilityEndometriosis groupHigher total gonadotropin requirementsTubal factor groupTwo-pronuclear oocytesReproductive technology cyclesPresence of endometriosisHigher cancellation rateAssessment of oocytesOvarian reserveGonadotropin requirementsIVF treatmentIVF programDelivery rateEmbryo gradeMature folliclesEndometriosisSperm injectionCancellation ratePatientsDay 2Peak E2
2004
Endometriosis and Inflammation in Infertility
HALIS G, ARICI A. Endometriosis and Inflammation in Infertility. Annals Of The New York Academy Of Sciences 2004, 1034: 300-315. PMID: 15731321, DOI: 10.1196/annals.1335.032.Peer-Reviewed Original ResearchConceptsPeritoneal fluidEndometriosis-associated inflammationTubal factor infertilityRate of womenReproductive failureProinflammatory mediatorsFactor infertilityInflammatory factorsPregnancy rateEndometriosisAdvanced stageAngiogenic factorsConfounding factorsInflammationGrowth factorInfertilityWomenReproductive technologiesRecent dataRecent reportsReproductive organsElevated amountsAspects of reproductionFactorsFailure
1999
Prospective, randomized, crossover study to evaluate the benefit of human chorionic gonadotropin–timed versus urinary luteinizing hormone–timed intrauterine inseminations in clomiphene citrate–stimulated treatment cycles
Zreik T, Garcı́a-Velasco J, Habboosh M, Olive D, Arici A. Prospective, randomized, crossover study to evaluate the benefit of human chorionic gonadotropin–timed versus urinary luteinizing hormone–timed intrauterine inseminations in clomiphene citrate–stimulated treatment cycles. Fertility And Sterility 1999, 71: 1070-1074. PMID: 10360912, DOI: 10.1016/s0015-0282(99)00116-8.Peer-Reviewed Original ResearchConceptsPregnancy rateClomiphene citrateCrossover studyUltrasound monitoringUrinary LH levelsReproductive Medicine CenterMale factor infertilityOverall pregnancy rateHCG timingLeading follicleUnexplained infertilityLH levelsUrinary LHFactor infertilityIntrauterine inseminationMenstrual cycleInfertile couplesMAIN OUTCOMEMedicine CenterProtocol BProtocol ADay 3IUITreatment cyclesDay 10
1998
HOXA10 is expressed in response to sex steroids at the time of implantation in the human endometrium.
Taylor H, Arici A, Olive D, Igarashi P. HOXA10 is expressed in response to sex steroids at the time of implantation in the human endometrium. Journal Of Clinical Investigation 1998, 101: 1379-1384. DOI: 10.1172/jci1057.Peer-Reviewed Original ResearchExpression of HOXA10Menstrual cycleTime of implantationSex steroidsCultured endometrial cellsUterine factor infertilityEffects of estrogenFactor infertilityEndometrial developmentEndometrial cellsHuman endometriumMidsecretory phaseHuman uterusPhysiologic rangeProgesteroneHOXA10Targeted disruptionNorthern blot analysisBlot analysisEstrogenSteroidsImplantationSitu hybridizationNovel regulatorExpression
1994
Evaluation of clomiphene citrate and human chorionic gonadotropin treatment: a prospective, randomized, crossover study during intrauterine insemination cycles
Arici A, Byrd W, Bradshaw K, Kutteh W, Marshburn P, Carr B. Evaluation of clomiphene citrate and human chorionic gonadotropin treatment: a prospective, randomized, crossover study during intrauterine insemination cycles. Fertility And Sterility 1994, 61: 314-318. PMID: 8299789, DOI: 10.1016/s0015-0282(16)56524-8.Peer-Reviewed Original ResearchConceptsPregnancy rateHCG timingInfertility groupUnexplained infertilityUltrasound monitoringMale factor infertility groupTertiary academic medical centerHuman chorionic gonadotropin treatmentClomiphene citrate stimulationUnexplained infertility groupIntrauterine insemination cyclesChorionic gonadotropin treatmentMale factor infertilityAcademic medical centerEffect of treatmentClomiphene citrateUrinary LHCrossover studyFactor infertilityInsemination cyclesGonadotropin treatmentCitrate stimulationTreatment modalitiesCC stimulationMedical Center